Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen

Clicks: 433
ID: 272824
2014
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #9 of 30 articles by views in intensive care medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Despite an amikacin dose of 25 mg/kg of total body weight, 33% of patients still had an amikacin Cmax < 60 mg/L. Positive 24-h fluid balance was identified as a predictive factor of Cmax < 60 mg/L. When total body weight is used, low BMI tended to be associated with amikacin underdosing. These …
Reference Key
e2014intensivepredictors Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors de Montmollin E, Bouadma L, Gault N, Mourvillier B, Mariotte E, Chemam S, Massias L, Papy E, Tubach F, Wolff M, Sonneville R
Are you one of these authors? Claim your profile
Journal intensive care medicine
Year 2014
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/24687298
Keywords
injections National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine female male aged middle aged Prospective Studies risk factors body mass index multivariate analysis observational study anti-bacterial agents / administration & dosage* dose-response relationship drug intensive care units critical illness intravenous body weight* infusions gram-negative bacterial infections / drug therapy amikacin / administration & dosage* pmid:24687298 doi:10.1007/s00134-014-3276-x etienne de montmollin lila bouadma romain sonneville amikacin / blood* anti-bacterial agents / blood*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.